Michael Glen Bankson - Publications
Affiliations: | 2001 | University of Texas Medical Branch, Galveston, TX |
Area:
pharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Amato JL, Bankson MG, Yamamoto BK. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 946-54. PMID 16885935 DOI: 10.1038/Sj.Npp.1301174 | 0.705 | |||
2006 | Breier JM, Bankson MG, Yamamoto BK. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 290-9. PMID 16399699 DOI: 10.1523/Jneurosci.3353-05.2006 | 0.673 | |||
2004 | Bankson MG, Yamamoto BK. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. Journal of Neurochemistry. 91: 852-9. PMID 15525339 DOI: 10.1111/J.1471-4159.2004.02763.X | 0.616 | |||
2002 | Bankson MG, Cunningham KA. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 40-52. PMID 11751031 DOI: 10.1016/S0893-133X(01)00345-1 | 0.529 | |||
2001 | Bankson MG, Cunningham KA. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. The Journal of Pharmacology and Experimental Therapeutics. 297: 846-52. PMID 11356903 | 0.563 | |||
1999 | McCreary AC, Bankson MG, Cunningham KA. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. The Journal of Pharmacology and Experimental Therapeutics. 290: 965-73. PMID 10454466 | 0.592 | |||
Show low-probability matches. |